Arineta gets FDA approval for Spotlight CT device
Ubicación actual:
> This Story

Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment




X-Ray Homepage

CT scans link progression of emphysema to air pollution Severity roughly equal to smoking a pack a day for 29 years

X-ray reveals grill-brush wire behind woman's dangerous breathing ills Half-inch bristle had been grilled onto a seared hot dog

X-ray scan reveals more than 500 teeth lodged in boy’s jaw Doctors determine cause to be compound composite ondontoma

Swedish court upholds C-RAD as owner of patent for imaging detector invention Part of lawsuit between C-RAD and Beamocular

Rate of pregnant women undergoing CT scans rising dramatically Researchers advise considering medical necessity before undergoing scans

Progenics collabs with VA on AI research for prostate cancer treatment Apply machine learning to medical images

The reimagined X-ray that may change the world Ran Poliakine, founder of Nanox, discusses why cold cathode X-rays may finally democratize access to medical imaging exams globally

New study links low dose radiation to increased cancer risk Exposure gives cancer-capable cells 'a boost' over normal cells

Neurologica agrees to discounts for Strategic Radiology members Discounts on digital radiography and ultrasound, software and services

New AI solution identifies high-risk patients from chest X-rays MGH tool may help detect heart disease, lung cancer

Arineta gets FDA approval for Spotlight CT device

por Thomas Dworetzky , Contributing Reporter
Sometimes all you really need is a CT scan of the heart – and thanks to a novel scanner from an Israeli company, you may soon be able to get exactly that.

Arineta's Spotlight CT scanner just received FDA 510(k) clearance for commercial distribution.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

The scanner will allow “a high performance, cardiovascular-dedicated CT, which provides a complete cardiac imaging solution at a lower cost and higher performance than conventional whole-body CT equipment,” according to a company statement.

The machine's “proprietary design” is “radically different from the design of the general purpose multi-slice CT scanners,” noted the company, adding that it was conceived “in close cooperation with cardiologists for cardiologists.”

Arineta cofounder and CEO Dr. Ehud Dafni is not a newcomer to CT-design invention, he told Israeli financial news daily Globes. “The last real revolution in CT was when a scanner was developed with two slices at Elscint 24 years ago. It happens to be my invention and that of David Ruimi, who is working with us now. That's the basis for every CT with slices there is today, up to 360 slices. At Arineta, we're not doing what everyone else does; we use multiple sources of radiation. We have only two right now, but we're developing a new generation of multiple sources, [among] the entire imaging industry."

Arineta's scanner does 3-D mapping of the heart and blood vessels to diagnose heart attacks in real time. Today CT is not the diagnostic tool of choice for those patients because it is too costly, has a relatively high radiation exposure and is relatively inaccurate because the heart is moving too much, according to Dafni.

Arineta's scanner images the heart in one sixth of a second – fast enough to get a clean image. It emits radiation in two directions at once, focused only on the heart and then uses proprietary computations to create a accurate 3-D picture, according to Globes.

Investors, mainly private ones, have put $13.5 million into the firm since it began in 2006, according to the Israeli financial business site. Beyond the private money, the firm had also previously inked a strategic agreement with CT giant GE Healthcare, although the deal does not include an option to buy.

"We are not interested in being acquired right now, but we are interested in an investment for production and support for marketing," Dafni told Globes, adding that the FDA approval “is a milestone for the company. The U.S. is the first market we're aiming at, and you can't market the device, or even offer marketing material to doctors, before you get approval. Some doctors, however, have already expressed interest in principle in our product, and I believe that we'll sign deals this year or early next year, and will already increase our sales in the ensuing year.”

CT devices run from $300,000 to $2 million, said Dafni, and the Spotlight will be “substantially cheaper than a high-end device."

X-Ray Homepage

You Must Be Logged In To Post A Comment